Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease

NCT07294586 is registered in ClinicalTrials.gov with Amoneta Diagnostics SAS as lead sponsor.

NCT NCT07294586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07294586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease
Lead sponsor
Amoneta Diagnostics SAS
Phase
Observational
Overall status
Completed
Start date
October 28, 2019
Completion date
June 24, 2021
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive decline, dementia, early onset alzheimer disease, late onset alzheimer disease, memory loss, mild cognitive impairment (mci), neurodegenerative disorders